Prolacta Bioscience, Inc.

Prolacta Bioscience, Inc.

Prolacta Bioscience, Inc.

Overview
Date Founded

1999

Headquarters

757 Baldwin Park Boulevard,City of Industry, CA 91746

Type of Company

Private

Employees (Worldwide)

51 - 100

Industries

Biotechnology
Retail: Other
Holding Companies
Consumer Services

Company Description

Prolacta Bioscience, Inc. provides specialty formulations of human milk for the nutritional needs of premature and critically ill infants. Its products include Prolact+ H2MF, Prolact+4, Prolact+6, Prolact+8, Prolact+10 and Neo20. The company was founded by Elena Taggart Medo in1999 and is headquartered in City of Industry, CA.

Contact Data
Trying to get in touch with decision makers at Prolacta Bioscience, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer & Director

Chief Financial Officer

Vice President, Legal Affairs, General Counsel & Corporate Secretary

Chief Information Officer

Chief Information Officer

Chief Medical & Scientific Officer

Chief Medical Officer

General Manager, Regulatory Affairs & Quality

Vice President-Medical Affairs

Board of Directors

Former President-Bioscience Division at Baxter BioScience Corp.

Co-Founder at Essex Woodlands Management, Inc.

President & Vice President at Alta Partners III, Inc.

Independent Healthcare Consultant at Sally W. Crawford, LLC

Executive Chairman at Health Evolution

Managing General Partner at Gideon Hixon Fund

Former President-Nutritional Products Division at Gerber Products Co., Inc.

Partner at Aisling Capital

Paths to Prolacta Bioscience, Inc.
Potential Connections via
Relationship Science
You
Prolacta Bioscience, Inc.
Recent Transactions
Details Hidden

Prolacta Bioscience, Inc. raised money in a private placement transaction

Details Hidden

Prolacta Bioscience, Inc. raised money in a private placement transaction

Details Hidden

Prolacta Bioscience, Inc. raised money in a private placement transaction

Clients

Cook Children's Medical Center provides surgery rehabilitation and ancillary equipment services. The firm offers equipment, surgery, rehabilitation and ancillary services all designed to meet children's needs. The company was founded in 1985 and is headquartered in Fort Worth, TX.

Non-Profit Donations & Grants
$250 - $499
2007
Investors
Details Hidden

Health Evolution Management focuses on long-term investments in healthcare companies that provide services, technologies and information solutions that improve the delivery, organization and financing of healthcare.The Health Evolution Partners Growth and Buyout Fund is a $500 million fund that invests in late stage healthcare companies. The fund focuses on investments in successful companies that have the potential to become market leaders and to improve value to end users. The fund makes growth and late stage investments in companies that are EBITDA positive or that have a demonstrated pathway to EBITDA growth. Investments may take the form of expansion capital, recapitalizations, buyouts, spin-offs and other forms of late stage financing. Health Evolution Management focuses on companies with sustainable competitive advantages, strong management teams and proprietary healthcare technology and processes. Initial equity investments range from $20 million to $80 million.Health Evolution Management developed the Health Evolution Partners Innovation Network (HEPIN), a $200 million fund supported by a partnership between the firm and a small number of early-stage venture capital funds. Partner funds work with Health Evolution Management to move innovations from idea to proof-of-concept and to develop leading management teams of the future. Health Evolution Management invests directly in portfolio companies and also invests into partnered venture funds.The firm's direct investments in portfolio companies take the form of lead investments and co-investments with HEPIN fund partners. Health Evolution Management may also invest in syndication with other funds. The firm seeks to invest in healthcare services, technology, diagnostics and medical devices that have the potential to establish a leadership position in a niche market, become the foundation for a solution platform or offer an innovation or disruption that can be integrated into an existing solution platform. They prefer to invest in opportunities in which significant engineering, science and regulatory risk does not exist. The firm also prefers to invest in companies operating in large markets with favorable growth trends and supportive regulatory and reimbursement environments. Health Evolution Management plays an active role in their investments taking board seats with all lead investments and at least board observation rights with co-investments. Initial equity investments range from $5 million to $10 million with capital reserved to maintain the firm's pro rata ownership.

Details Hidden

Draper Associates invests in seed to early stage requirements. The firm targets companies operating in the fields of consumer technology, financial technology, healthcare, manufacturing, education, and government technologies.

Details Hidden

DFJ Frontier focuses on investments in seed and early-stage technology companies located in the west coast of the US. The firm has a particular interest in emerging technologies and considers investments in any market-driven technology opportunity including software, information services, biotechnology, nanotechnology and alternative energy. DFJ Frontier typically leads the first round of investment and takes an active role on their portfolio companies' boards of directors. Initial investments generally range from $100,000 to $1 million, with additional capital reserved for follow-on investment. DFJ Frontier structures syndicates for opportunities that require larger initial capital infusions.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Prolacta Bioscience, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Prolacta Bioscience, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Prolacta Bioscience, Inc..